BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
116.57
+5.68 (5.12%)
At close: Aug 21, 2026, 4:00 PM EDT
116.71
+0.14 (0.12%)
After-hours: Aug 21, 2026, 7:59 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $29.28 billion as of August 21, 2026. Its market cap has increased by 9.44% in one year.
Market Cap
29.28B
Enterprise Value
14.26B
1-Year Change
9.44%
Ranking
Category
Stock Price
$116.57
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $29.28B, an increase of 877.73%. That is a compound annual growth rate of 39.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 29.28B | 27.92% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 45.38B |
| BeOne Medicines AG | 41.97B |
| Royalty Pharma | 34.83B |
| Alnylam Pharmaceuticals | 30.68B |
| Insmed | 27.32B |
| Roivant Sciences | 26.62B |
| Incyte | 25.79B |
| Genmab | 19.98B |